Literature DB >> 25108706

Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1α and opioid receptors in experimental rats.

Jian Wu1, Peng Li, Xiuying Wu, Weimin Chen.   

Abstract

PURPOSE: The present study was designed to determine the effects of chronic intermittent hypoxia (CIH) on pain sensitivity and the changes in the expression of delta-opioid receptor (DOR), mu-opioid receptor (MOR), and hypoxia-inducible factor (HIF)-1α and their relationship with pain sensitivity under hypoxia.
METHODS: CIH was employed to model the low oxygen condition in obstructive sleep apnea (OSA). Normal oxygen condition was used as control. After 1-, 2-, 3-, and 4-week hypoxia, behavioral tests, including paw-withdrawal latency (PWL) and paw-withdrawal threshold (PWT), were performed. The expressions of DOR, MOR and HIF-1α in cortex were analyzed by real-time PCR and Western blotting.
RESULTS: HIF-1α expression was significantly upregulated after 1-4 weeks of hypoxia at both mRNA and protein levels, compared with the controls (P < 0.05). Both PWL and PWT were significantly enhanced in the rats following 3 and 4 weeks of hypoxia (P < 0.05). DOR and MOR expression was significantly upregulated at both mRNA and protein levels after 3 and 4 weeks of hypoxia (P < 0.05), which corresponded to the behavioral changes.
CONCLUSIONS: CIH decreases pain sensitivity in rats, possibly through activating HIF-1α and increasing MOR and DOR expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25108706     DOI: 10.1007/s11325-014-1047-0

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  34 in total

Review 1.  Sleep-disordered breathing and cardiovascular disorders.

Authors:  Rohit Budhiraja; Pooja Budhiraja; Stuart F Quan
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

2.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

3.  Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.

Authors:  Miquel Martin; Audrey Matifas; Rafael Maldonado; Brigitte L Kieffer
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

4.  Recurrent hypoxemia in young children with obstructive sleep apnea is associated with reduced opioid requirement for analgesia.

Authors:  Karen A Brown; André Laferrière; Immanuela Ravé Moss
Journal:  Anesthesiology       Date:  2004-04       Impact factor: 7.892

5.  Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide.

Authors:  Dan Kaufmann; Boris Yagen; Anne Minert; Michael Tal; Marshall Devor; Meir Bialer
Journal:  Neuropharmacology       Date:  2007-12-08       Impact factor: 5.250

6.  Neuropathic pain is enhanced in delta-opioid receptor knockout mice.

Authors:  Xavier Nadal; Josep-Eladi Baños; Brigitte L Kieffer; Rafael Maldonado
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

7.  Sleep onset insomnia symptoms during hospitalization for major burn injury predict chronic pain.

Authors:  Michael T Smith; Brendan Klick; Sharon Kozachik; Robert E Edwards; Radha Holavanahalli; Shelley Wiechman; Patricia Blakeney; Dennis Lezotte; James A Fauerbach
Journal:  Pain       Date:  2008-03-24       Impact factor: 6.961

Review 8.  Opioid receptor genes inactivated in mice: the highlights.

Authors:  C Gavériaux-Ruff; B L Kieffer
Journal:  Neuropeptides       Date:  2002 Apr-Jun       Impact factor: 3.286

9.  Ang II type 1 receptor expression in rat aorta exposed to chronic intermittent hypoxia: effects of p38MAPK and ERK1/2 signaling.

Authors:  Jin Shang; Yuan-Yuan Yang; Xue-Ling Guo; Hui-Guo Liu
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

10.  Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea.

Authors:  Anthony G Doufas; Lu Tian; Kevin A Padrez; Puntarica Suwanprathes; James A Cardell; Holden T Maecker; Periklis Panousis
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more
  8 in total

1.  Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein.

Authors:  Agata Gabryelska; Bartosz Szmyd; Janusz Szemraj; Robert Stawski; Marcin Sochal; Piotr Białasiewicz
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

2.  Effect of different levels of intermittent hypoxia on autophagy of hippocampal neurons.

Authors:  Shuling Song; Jin Tan; Yuyang Miao; Qiang Zhang
Journal:  Sleep Breath       Date:  2017-05-29       Impact factor: 2.816

3.  The effect of chronic intermittent hypoxia on respiratory sensitivity to morphine in rats.

Authors:  Jian Wu; Peng Li; Xiuying Wu
Journal:  Sleep Breath       Date:  2017-01-03       Impact factor: 2.816

4.  Effects of Obstructive Sleep Apnea and Obesity on Morphine Pharmacokinetics in Children.

Authors:  Nicholas M Dalesio; Carlton K K Lee; Craig W Hendrix; Nikole Kerns; Aaron Hsu; William Clarke; Joseph M Collaco; Sharon McGrath-Morrow; Myron Yaster; Robert H Brown; Alan R Schwartz
Journal:  Anesth Analg       Date:  2020-09       Impact factor: 6.627

5.  Normalizing JMJD6 Expression in Rat Spinal Dorsal Horn Alleviates Hyperalgesia Following Chronic Constriction Injury.

Authors:  Cheng Mo; Mengyuan Xu; Cen Wen; Ruimin Chang; Changsheng Huang; Wangyuan Zou; Xiaoyan Zhu; Qulian Guo
Journal:  Front Neurosci       Date:  2018-08-07       Impact factor: 4.677

6.  Resolution of fibromyalgia by controlling obstructive sleep apnea with a mandibular advancement device.

Authors:  Fernanda Vantine; Dominik Ettlin; Miguel Meira-E-Cruz
Journal:  Sleep Sci       Date:  2021 Jul-Sep

Review 7.  The Role of Inflammation, Hypoxia, and Opioid Receptor Expression in Pain Modulation in Patients Suffering from Obstructive Sleep Apnea.

Authors:  Piotr Kaczmarski; Filip Franciszek Karuga; Bartosz Szmyd; Marcin Sochal; Piotr Białasiewicz; Dominik Strzelecki; Agata Gabryelska
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

8.  Chronic widespread musculoskeletal pain in patients with obstructive sleep apnea syndrome and the relationship between sleep disorder and pain level, quality of life, and disability.

Authors:  Ebru Aytekin; Saliha Eroglu Demir; Ece Akyol Komut; Sibel Caglar Okur; Ozer Burnaz; Nil Sayiner Caglar; Dilay Yilmaz Demiryontar
Journal:  J Phys Ther Sci       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.